Dr Catharine Porter
Research Associate - Statistics
- porterc3@cardiff.ac.uk
- +44 (0)29 2068 7459
- 514, Neuadd Meirionnydd, University Hospital of Wales, Heath Park, Cardiff, CF14 4YS
Overview
I am a Research Associate in Statistics in the Centre for Trials Research at Cardiff University where I have worked since September 2014. My main areas of interest are solid tumour and haematology trials. I have previously worked for many years as a Data Manager in Clinical Haematology and have extensive experience of Haematology Clinical trials.
I am a PhD in Biochemistry (University of Birmingham) and Master in Public Health (Cardiff University).
Biography
Education and Qualifications
- 2014: Masters In Public Health, Cardiff University, UK
- 1989: PhD (Biochemistry), Birmingham University, UK
- 1985: BSc (Hons) Biological Sciences, University of East Anglia
Career overview
- January 2019 to present: Research Associate (Statistics), Centre for Trials Research, Cardiff University
- October 2017-January 2019: Acting Research Associate (Statistics), Centre for Trials Research, Cardiff University
- 2014-October 2017: Research Assistant (Statistics), Wales Cancer Trials Unit, Cardiff University
- 2001-2005: Data Coordinator, Clinical Haematology and Bone Marrow Transplant Unit, University Hospital Birmingham
- 1998-2001: Data Manager, Clinical Haematology and Bone Marrow Transplant Unit, Birmingham Heartlands Hospital
Academic positions
- 1989-1993: Post-doctoral Research Fellow, School of Biological Sciences, Birmingham University
Publications
We are currently unable to retrieve the list of publications. Visit our institutional repository.My research interests are clinical trials in oncology, both solid tumours and haematology.
As a trial statistician I am involved in clinical trials from trial design through to final analysis and publication, producing interim analysis for data monitoring committees and central monitoring of data.
I am currently working on Phase 1-3 trials in acute lymphoblastic leukaemia, anal cancer, pleural mesothelioma, lung cancer, oesophageal cancer and endometrial cancer.
I am also involved as an Independent member on Data Monitoring Committees.